Turk Ilac ve Serumnayi (IST:TRILC) Days Sales Outstanding : 122.39 (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Turk Ilac ve Serumnayi Days Sales Outstanding?

Turk Ilac ve Serumnayi's average Accounts Receivable for the three months ended in Sep. 2023 was ₺585 Mil. Turk Ilac ve Serumnayi's Revenue for the three months ended in Sep. 2023 was ₺436 Mil. Hence, Turk Ilac ve Serumnayi's Days Sales Outstanding for the three months ended in Sep. 2023 was 122.39.

The historical rank and industry rank for Turk Ilac ve Serumnayi's Days Sales Outstanding or its related term are showing as below:

IST:TRILC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 110.1 Med: 155.11 Max: 222.33
Current: 146.35

During the past 6 years, Turk Ilac ve Serumnayi's highest Days Sales Outstanding was 222.33. The lowest was 110.10. And the median was 155.11.

IST:TRILC's Days Sales Outstanding is ranked worse than
89.29% of 999 companies
in the Drug Manufacturers industry
Industry Median: 71.7 vs IST:TRILC: 146.35

Turk Ilac ve Serumnayi's Days Sales Outstanding declined from Sep. 2022 (152.34) to Sep. 2023 (122.39).

Turk Ilac ve Serumnayi Days Sales Outstanding Historical Data

The historical data trend for Turk Ilac ve Serumnayi's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Turk Ilac ve Serumnayi Days Sales Outstanding Chart

Turk Ilac ve Serumnayi Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Sales Outstanding

Get a 7-Day Free Trial

147.14

185.16

222.33

110.10

143.02

Turk Ilac ve Serumnayi Quarterly Data
	Dec17	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Days Sales Outstanding	Get a 7-Day Free Trial														152.34	199.49	121.36	164.83	122.39

Competitive Comparison of Turk Ilac ve Serumnayi's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Turk Ilac ve Serumnayi's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Turk Ilac ve Serumnayi's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Turk Ilac ve Serumnayi's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Turk Ilac ve Serumnayi's Days Sales Outstanding falls into.

Turk Ilac ve Serumnayi Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Turk Ilac ve Serumnayi's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (262.258	+	390.899)	/	2 )	/	833.438	*	365
=	326.5785					/	833.438	*	365
=	143.02

Turk Ilac ve Serumnayi's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

	Days Sales Outstanding (Q: Sep. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Sep. 2023 ))	/	count )	/	Revenue (A: Sep. 2023 )	*	Days in Period
=	( (446.66	+	722.563)	/	2 )	/	435.882	*	365 / 4
=	584.6115					/	435.882	*	365 / 4
=	122.39

Turk Ilac ve Serumnayi (IST:TRILC) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Turk Ilac ve Serumnayi Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Turk Ilac ve Serumnayi's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Turk Ilac ve Serumnayi (IST:TRILC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Turk Ilac ve Serum Sanayi (IST:TRILC) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bügduz Mah. Enver Pasa Cad., No: 8 Akyurt, Ankara, TUR, TR 06750

Website

http://www.turkilac.com.tr

Turk Ilac ve Serum Sanayi is engaged in the production of human pharmaceuticals and vaccines.

Turk Ilac ve Serumnayi (IST:TRILC) Headlines

No Headlines